HUM · News · 20260809N

Generic Drug Price-Fixing Litigation

HUMANA INC · 2026-08-09 · Importance 23 · Surprise 24

Teva Pharmaceuticals asked a U.S. judge to prevent Humana from telling jurors that Teva has Israeli origins in an upcoming generic-drug price-fixing trial. Teva argued that public sentiment related to the Gaza war could prejudice the jury and undermine its ability to receive a fair hearing. The case involves Humana as an insurer and could affect the company’s recovery or claims associated with alleged generic-drug price fixing, although the report provides no quantified financial exposure.

Key facts

• Teva Pharmaceuticals has requested that a U.S. judge prevent insurer Humana from revealing its Israeli origins to jurors in an upcoming price-fixing trial. source
• Teva argued that strong public sentiment regarding the Gaza war could prejudice the proceedings and hinder its ability to receive a fair hearing. source